跳至主要内容
临床试验/NCT02988375
NCT02988375已完成不适用

Sleep to Prevent Evolving Affecting Disorders

Henry Ford Health System2 个研究点 分布在 1 个国家目标入组 1,385 人开始时间: 2016年3月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,385
试验地点
2
主要终点
Severity of Symptoms of Insomnia [Time Frame: Pre-treatment (Day 1)]

研究概览

简要总结

The primary objective of the proposed research is to determine the efficacy of Digital Cognitive Behavior Therapy (dCBTI) in reducing severity of depression and also in preventing the incidence and relapse of depression among insomniacs. In addition, we will identify salient sociological/environmental variables, such as age, sex, education, socioeconomic status (SES), racial/ethnic minority-status, work schedule, child-care responsibilities (i.e., having children under the age of 3), stigma, that moderate the effects of this intervention.

详细描述

The purpose of this study is to determine the effectiveness of Digital Cognitive Behavior Therapy for Insomnia (dCBTI) in reducing severity of depression and also in preventing the incidence and relapse of depression among insomniacs. dCBTI is an online form of Cognitive Behavioral Therapy (CBT) used with people who experience trouble sleeping at night (insomniacs). This study will allow us to determine whether this form of digital therapy is helpful in reducing the severity of depression and in preventing the development and relapse of depression in people suffering from insomnia.

Participants will be recruited from several well-developed sources, including the HFHS Sleep Center Clinical database. Once a participant meets inclusion criteria and provides consent, a link to the internet portal will be provided to complete the remaining survey questions. After completion of this assessment, participants will be automatically randomized to one of 2 active online insomnia treatment conditions. Each treatment involves 6 weekly "sessions" which each take up to 20 minutes to complete.

A post-treatment questionnaire immediately following the 6-week treatment phase will be completed. In addition, a follow up questionnaire assessment will be completed approximately 1 year after treatment. Each of the 3 separate questionnaires will take 20-30 minutes to complete. Participants will be compensated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Meets Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition(DSMV) criteria for insomnia

排除标准

  • Lack of insomnia, untreated sleep disorder (e.g., obstructive sleep apnea, restless leg syndrome), bipolar disorder, history of seizure disorder, high depression chronicity (self-reported daily or near daily depressed mood and anhedonia)

结局指标

主要结局

Severity of Symptoms of Insomnia [Time Frame: Pre-treatment (Day 1)]

时间窗: Pre-treatment (Day 1)

Insomnia Severity Index Score (ISI; total score range 0-28, with higher scores meaning greater severity)

Severity of Depression as Measured by the Quick Inventory of Depressive Symptomatology (QIDS) Pre-Treatment

时间窗: Pre-treatment (Day 1)

Severity of depression as measured by the Quick Inventory of Depressive Symptomatology (QIDS; ranges 0-27 with higher scores meaning greater severity) and incidence of depression

Severity of Depression as Measured by the Quick Inventory of Depressive Symptomatology (QIDS), 1-year Follow-up

时间窗: 1-year follow-up (58 week after screening)

Severity of depression as measured by the Quick Inventory of Depressive Symptomatology (QIDS; ranges 0-27 with higher scores meaning greater severity)

Severity of Depression as Measured by the Quick Inventory of Depressive Symptomatology (QIDS) Post-Treatment

时间窗: Post-treatment (~6 week after Screening)

Severity of depression as measured by the Quick Inventory of Depressive Symptomatology (QIDS; ranges 0-27 with higher scores meaning greater severity)

次要结局

  • Severity of Symptoms of Insomnia - Post Treatment(Post-treatment (~6 week after Screening))
  • Severity of Symptoms of Insomnia - 1 Year Post Treatment(1-year follow-up (58 week after screening))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christopher Drake

Director of Sleep Research

Henry Ford Health System

研究点 (2)

Loading locations...

相似试验